104 related articles for article (PubMed ID: 15041108)
1. Morbidity of prostatic biopsy for different biopsy strategies: is there a relation to core number and sampling region?
Paul R; Schöler S; van Randenborgh H; Kübler H; Alschibaja M; Busch R; Hartung R
Eur Urol; 2004 Apr; 45(4):450-5; discussion 456. PubMed ID: 15041108
[TBL] [Abstract][Full Text] [Related]
2. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
[TBL] [Abstract][Full Text] [Related]
3. Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study.
Djavan B; Waldert M; Zlotta A; Dobronski P; Seitz C; Remzi M; Borkowski A; Schulman C; Marberger M
J Urol; 2001 Sep; 166(3):856-60. PubMed ID: 11490233
[TBL] [Abstract][Full Text] [Related]
4. Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores.
Naughton CK; Ornstein DK; Smith DS; Catalona WJ
J Urol; 2000 Jan; 163(1):168-71. PubMed ID: 10604338
[TBL] [Abstract][Full Text] [Related]
5. Optimization of prostatic biopsy: a prospective randomized trial comparing the sextant biopsy with a 10-core biopsy. Impact of prostatic region of sampling.
Paul R; Schöler S; van Randenborgh H; Kübler H; Alschibaja M; Busch R; Hartung R
Urol Int; 2005; 74(3):203-8. PubMed ID: 15812204
[TBL] [Abstract][Full Text] [Related]
6. Increasing prostate biopsy cores based on volume vs the sextant biopsy: a prospective randomized controlled clinical study on cancer detection rates and morbidity.
Mariappan P; Chong WL; Sundram M; Mohamed SR
BJU Int; 2004 Aug; 94(3):307-10. PubMed ID: 15291857
[TBL] [Abstract][Full Text] [Related]
7. An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer.
Eskicorapci SY; Baydar DE; Akbal C; Sofikerim M; Günay M; Ekici S; Ozen H
Eur Urol; 2004 Apr; 45(4):444-8; discussion 448-9. PubMed ID: 15041107
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and morbidity of transrectal ultrasound-guided 12-core biopsy for detection of prostate cancer in Japanese men.
Matsumoto K; Satoh T; Egawa S; Shimura S; Kuwao S; Baba S
Int J Urol; 2005 Apr; 12(4):353-60. PubMed ID: 15948721
[TBL] [Abstract][Full Text] [Related]
9. Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol.
Ghani KR; Dundas D; Patel U
BJU Int; 2004 Nov; 94(7):1014-20. PubMed ID: 15541119
[TBL] [Abstract][Full Text] [Related]
10. Pain and morbidity of an extensive prostate 10-biopsy protocol: a prospective study in 289 patients.
Peyromaure M; Ravery V; Messas A; Toublanc M; Boccon-Gibod L; Boccon-Gibod L
J Urol; 2002 Jan; 167(1):218-21. PubMed ID: 11743309
[TBL] [Abstract][Full Text] [Related]
11. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.
Stamatiou K; Alevizos A; Karanasiou V; Mariolis A; Mihas C; Papathanasiou M; Bovis K; Sofras F
Urol Int; 2007; 78(4):313-7. PubMed ID: 17495488
[TBL] [Abstract][Full Text] [Related]
12. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
[TBL] [Abstract][Full Text] [Related]
13. Detection of prostate cancer: comparison of cancer detection rates of sextant and extended ten-core biopsy protocols.
Ojewola RW; Tijani KH; Jeje EA; Anunobi CC; Ogunjimi MA; Ezenwa EV; Ogundiniyi OS
Niger Postgrad Med J; 2012 Sep; 19(3):137-42. PubMed ID: 23064168
[TBL] [Abstract][Full Text] [Related]
14. Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores.
Berger AP; Gozzi C; Steiner H; Frauscher F; Varkarakis J; Rogatsch H; Bartsch G; Horninger W
J Urol; 2004 Apr; 171(4):1478-80; discussion 1480-1. PubMed ID: 15017202
[TBL] [Abstract][Full Text] [Related]
15. Impact of transrectal ultrasound guided prostate biopsy on quality of life: a prospective randomized trial comparing 6 versus 12 cores.
Naughton CK; Miller DC; Yan Y
J Urol; 2001 Jan; 165(1):100-3. PubMed ID: 11125374
[TBL] [Abstract][Full Text] [Related]
16. Safety and detailed patterns of morbidity of transrectal ultrasound guided needle biopsy of prostate in a urologist-led unit.
Lee G; Attar K; Laniado M; Karim O
Int Urol Nephrol; 2006; 38(2):281-5. PubMed ID: 16868698
[TBL] [Abstract][Full Text] [Related]
17. Diclofenac suppository analgesia for transrectal ultrasound guided biopsies of the prostate: a double-blind, randomized controlled trial.
Haq A; Patel HR; Habib MR; Donaldson PJ; Parry JR
J Urol; 2004 Apr; 171(4):1489-91. PubMed ID: 15017205
[TBL] [Abstract][Full Text] [Related]
18. [Puncture biopsy of the prostate].
Lechevallier E
Prog Urol; 1996; 6(4):507-18. PubMed ID: 8924925
[TBL] [Abstract][Full Text] [Related]
19. Indications for extended 14-core transrectal ultrasound-guided prostate biopsy.
Uno H; Nakano M; Ehara H; Deguchi T
Urology; 2008 Jan; 71(1):23-7. PubMed ID: 18242358
[TBL] [Abstract][Full Text] [Related]
20. Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of three-dimensional 26-core systematic biopsy.
Kawakami S; Okuno T; Yonese J; Igari T; Arai G; Fujii Y; Kageyama Y; Fukui I; Kihara K
Eur Urol; 2007 Mar; 51(3):675-82; discussion 682-3. PubMed ID: 16843585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
